Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 27, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 3, 2026
CEOIndirect holdingTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001298709-26-000002
Filed / recorded
Mar 3, 2026, 11:30 PM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Krystal Biotech, Inc.
Issuer CIK
1711279
Ticker
KRYS
Reporting person
Krish S Krishnan
Relationship
Director, Officer, 10% owner
Officer title
President and CEO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Feb 27, 2026
Transaction code
F
Shares / units
1,820
Price per share
$275.64
Acquired / disposed
Disposed (D)
Shares owned after
1,428,155
Ownership form
Indirect — By Spouse
Amendment
No
Footnotes from the filing
These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma M. Krishnan.
Represents number of shares of common stock surrendered to the Company for tax withholding by the Reporting Person's spouse, Suma M. Krishnan, upon the vesting of 4,000 RSUs on February 27, 2026.
The closing price on February 27, 2026 of the Company's common stock on the Nasdaq Global Select Market.
Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person.